Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 194

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation

Open access
Huurman, Volkert A. L., Hilbrands, Robert, Pinkse, Gabriëlle G. M., Gillard, Pieter, Duinkerken, Gaby, van de Linde, Pieter, van der Meer-Prins, Petronella M. W., Versteeg-van der Voort Maarschalk, Minke F. J., Verbeeck, Koen, Alizadeh, Behrooz Z., Mathieu, Chantal, Gorus, Frans K., Roelen, Dave L., Claas, Frans H. J., Keymeulen, Bart, Pipeleers, Daniel G., Roep, Bart O. · 2008 · PLoS ONE

Abstract

BACKGROUND: Islet cell transplantation can cure type 1 diabetes (T1D), but only a minority of recipients remains insulin-independent in the following years. We tested the hypothesis that allograft rejection and recurrent autoimmunity contribute to this progressive loss of islet allograft function. METHODOLOGY/PRINCIPAL FINDINGS: Twenty-one T1D patients received cultured islet cell grafts prepared from multiple donors and transplanted under anti-thymocyte globulin (ATG) induction and tacrolimus plus mycophenolate mofetil (MMF) maintenance immunosuppression. Immunity against auto- and alloantigens was measured before and during one year after transplantation. Cellular auto- and alloreactivity was assessed by lymphocyte stimulation tests against autoantigens and cytotoxic T lymphocyte precursor assays, respectively. Humoral reactivity was measured by auto- and alloantibodies. Clinical outcome parameters--including time until insulin independence, insulin independence at one year, and C-peptide levels over one year--remained blinded until their correlation with immunological parameters. All patients showed significant improvement of metabolic control and 13 out of 21 became insulin-independent. Multivariate analyses showed that presence of cellular autoimmunity before and after transplantation is associated with delayed insulin-independence (p = 0.001 and p = 0.01, respectively) and lower circulating C-peptide levels during the first year after transplantation (p = 0.002 and p = 0.02, respectively). Seven out of eight patients without pre-existent T-cell autoreactivity became insulin-independent, versus none of the four patients reactive to both islet autoantigens GAD and IA-2 before transplantation. Autoantibody levels and cellular alloreactivity had no significant association with outcome. CONCLUSIONS/SIGNIFICANCE: In this cohort study, cellular islet-specific autoimmunity associates with clinical outcome of islet cell transplantation under ATG-tacrolimus-MMF immunosuppression. Tailored immunotherapy targeting cellular islet autoreactivity may be required. Monitoring cellular immune reactivity can be useful to identify factors influencing graft survival and to assess efficacy of immunosuppression. TRIAL REGISTRATION: Clinicaltrials.gov NCT00623610.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0002435

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 194

Metadata

Authors
Huurman, V. A. L., Hilbrands, R., Pinkse, G. G. M., Gillard, P., Duinkerken, G., van de Linde, P., van der Meer-Prins, P. M. W., Versteeg-van der Voort Maarschalk, M. F. J., Verbeeck, K., Alizadeh, B. Z., Mathieu, C., Gorus, F. K., Roelen, D. L., Claas, F. H. J., Keymeulen, B., Pipeleers, D. G., & Roep, B. O.
Venue
PLoS ONE
Published
2008-06-18
Volume
3
Issue
6
Pages
e2435
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2008373133
Cited by
194
References
4
FWCI
11.25
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation. https://app.cochat.ai/papers/10.1371/journal.pone.0002435
The paper
Huurman, V. A. L., Hilbrands, R., Pinkse, G. G. M., Gillard, P., Duinkerken, G., van de Linde, P., van der Meer-Prins, P. M. W., Versteeg-van der Voort Maarschalk, M. F. J., Verbeeck, K., Alizadeh, B. Z., Mathieu, C., Gorus, F. K., Roelen, D. L., Claas, F. H. J., Keymeulen, B., Pipeleers, D. G., & Roep, B. O. (2008). Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation. PLoS ONE. https://doi.org/10.1371/journal.pone.0002435

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.